drugset / Trial / NCT06507332

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

NCT06507332

RandomizedParallel-groupOpen-labelTreatment

Summary

Clomiphene citrate is a non-steroidal triphenylethylene derivative distantly related to diethylstilbestrol. It acts as a selective estrogen receptor modulator (SERM), similar to tamoxifen and raloxifene. All three drugs are competitive inhibitors of estrogen binding to estrogen receptors (ERs) and have mixed agonist and antagonist activity, depending upon the target tissue. Letrozole is a potent, nonsteroidal, aromatase inhibitor, originally used for postmenopausal breast cancer therapy.

Timeline

Start
2024-03-01
Primary completion
2024-09-01
Completion
2024-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 50 mg
Comparator Letrozole Other / unclassified 2.5 mg Oral